India Unveils Breakthrough Gene Therapy for Cancer

President Droupadi Murmu launched India's inaugural home-grown gene therapy, CAR-T cell therapy, at IIT Bombay, marking a significant leap in the fight against cancer. This affordable treatment opens new avenues of hope globally.

Essential Highlights:

• Innovative Treatment: CAR-T cell therapy represents a remarkable stride in medical science, traditionally available only in developed countries due to its high cost.
  

• Accessibility and Affordability: The President emphasized the therapy's affordability and accessibility, making it a beacon of hope for cancer patients worldwide
  

• Make in India Initiative: This therapy exemplifies the 'Make in India' initiative, showcasing India's ability to produce pioneering and cost-effective healthcare solutions.
  

• Academia-Industry Collaboration: Developed through a partnership between IIT Bombay, Tata Memorial Hospital, and ImmunoACT, this project highlights the potential of academia-industry collaborations in advancing healthcare innovations.
  

Conclusion:

The launch of CAR-T cell therapy is a testament to India's commitment to affordable healthcare and its capacity to contribute significantly to global medical advancements.

Keywords to Remember:

• CAR-T Cell Therapy: A form of gene therapy that modifies a patient's T-cells to attack cancer cells.
  

• Affordable Healthcare: Healthcare services that are financially accessible to the majority of the population.
  

• Academia-Industry Partnership: Collaborations between educational institutions and industries for mutual benefit, especially in research and development.

Link to Article : Press Information Bureau (pib.gov.in)

Released On : 04 April 2024